244 related articles for article (PubMed ID: 19054819)
1. N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?
Allanore Y; Wahbi K; Borderie D; Weber S; Kahan A; Meune C
Ann Rheum Dis; 2009 Dec; 68(12):1885-9. PubMed ID: 19054819
[TBL] [Abstract][Full Text] [Related]
2. N-terminal Pro brain natriuretic peptide is a reliable biomarker of reduced myocardial contractility in patients with lamin A/C gene mutations.
Meune C; Wahbi K; Gobeaux C; Duboc D; Pecker F; Bonne G
Int J Cardiol; 2011 Sep; 151(2):160-3. PubMed ID: 20627339
[TBL] [Abstract][Full Text] [Related]
3. Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.
Dimitroulas T; Giannakoulas G; Papadopoulou K; Karvounis H; Dimitroula H; Koliakos G; Karamitsos T; Parcharidou D; Settas L
J Rheumatol; 2010 May; 37(5):993-9. PubMed ID: 20194451
[TBL] [Abstract][Full Text] [Related]
4. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
[TBL] [Abstract][Full Text] [Related]
5. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
[TBL] [Abstract][Full Text] [Related]
6. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
[TBL] [Abstract][Full Text] [Related]
7. Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
Jurisic Z; Martinovic-Kaliterna D; Marasovic-Krstulovic D; Perkovic D; Tandara L; Salamunic I; Carevic V
Rheumatology (Oxford); 2013 Jul; 52(7):1298-302. PubMed ID: 23538743
[TBL] [Abstract][Full Text] [Related]
8. Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis.
Ciurzyński M; Bienias P; Irzyk K; Kostrubiec M; Bartoszewicz Z; Siwicka M; Stelmaszczyk-Emmel A; Górska E; Demkow U; Pruszczyk P
Clin Rheumatol; 2014 Jan; 33(1):83-9. PubMed ID: 23942766
[TBL] [Abstract][Full Text] [Related]
9. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
[TBL] [Abstract][Full Text] [Related]
11. Left atrial stiffness is superior to volume and strain parameters in predicting elevated NT-proBNP levels in systemic sclerosis patients.
Porpáczy A; Nógrádi Á; Vértes V; Tőkés-Füzesi M; Czirják L; Komócsi A; Faludi R
Int J Cardiovasc Imaging; 2019 Oct; 35(10):1795-1802. PubMed ID: 31093897
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of N-terminal natriuretic peptides in systemic sclerosis: a single centre study.
Költő G; Vuolteenaho O; Szokodi I; Faludi R; Tornyos A; Ruskoaho H; Minier T; Czirják L; Komócsi A
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-75-81. PubMed ID: 25372791
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
[TBL] [Abstract][Full Text] [Related]
14. Troponin I and echocardiography in patients with systemic sclerosis and matched population controls.
Nordin A; Svenungsson E; Björnådal L; Elvin K; Larsson A; Jensen-Urstad K
Scand J Rheumatol; 2017 May; 46(3):226-235. PubMed ID: 27601074
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
[TBL] [Abstract][Full Text] [Related]
17. Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients.
Chighizola C; Meroni PL; Schreiber BE; Coghlan JG; Denton CP; Ong VH
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S81-5. PubMed ID: 22691215
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis.
Allanore Y; Komocsi A; Vettori S; Hachulla E; Hunzelmann N; Distler J; Avouac J; Gobeaux C; Launay D; Czirjak L; Kahan A; Meune C
Int J Cardiol; 2016 Nov; 223():385-389. PubMed ID: 27543715
[TBL] [Abstract][Full Text] [Related]
19. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
Hess G; Runkel S; Zdunek D; Hitzler WE
Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
